[go: up one dir, main page]

ATE521347T1 - Kombination aus einem bis-thiazol-salz oder einem vorläufer davon und artemisinin oder einem derivat davon zur behandlung akuter malaria - Google Patents

Kombination aus einem bis-thiazol-salz oder einem vorläufer davon und artemisinin oder einem derivat davon zur behandlung akuter malaria

Info

Publication number
ATE521347T1
ATE521347T1 AT09721879T AT09721879T ATE521347T1 AT E521347 T1 ATE521347 T1 AT E521347T1 AT 09721879 T AT09721879 T AT 09721879T AT 09721879 T AT09721879 T AT 09721879T AT E521347 T1 ATE521347 T1 AT E521347T1
Authority
AT
Austria
Prior art keywords
artemisinin
precursor
bis
derivative
treatment
Prior art date
Application number
AT09721879T
Other languages
English (en)
Inventor
Laurent Fraisse
Henri Vial
Sharon Aurore Wein
Original Assignee
Sanofi Sa
Centre Nat Rech Scient
Univ Montpellier Ii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39705083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE521347(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa, Centre Nat Rech Scient, Univ Montpellier Ii filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE521347T1 publication Critical patent/ATE521347T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT09721879T 2008-02-06 2009-02-05 Kombination aus einem bis-thiazol-salz oder einem vorläufer davon und artemisinin oder einem derivat davon zur behandlung akuter malaria ATE521347T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0800618A FR2926993B1 (fr) 2008-02-06 2008-02-06 Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme
PCT/FR2009/000129 WO2009115666A2 (fr) 2008-02-06 2009-02-05 Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artémisinine ou l'un de ses derives pour le traitement du paludisme severe

Publications (1)

Publication Number Publication Date
ATE521347T1 true ATE521347T1 (de) 2011-09-15

Family

ID=39705083

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09721879T ATE521347T1 (de) 2008-02-06 2009-02-05 Kombination aus einem bis-thiazol-salz oder einem vorläufer davon und artemisinin oder einem derivat davon zur behandlung akuter malaria

Country Status (39)

Country Link
US (1) US8304440B2 (de)
EP (1) EP2252286B1 (de)
JP (1) JP5469095B2 (de)
KR (1) KR20100137442A (de)
CN (1) CN101980706B (de)
AP (1) AP2613A (de)
AR (1) AR070581A1 (de)
AT (1) ATE521347T1 (de)
AU (1) AU2009227092B2 (de)
BR (1) BRPI0907484A2 (de)
CA (1) CA2714184A1 (de)
CL (1) CL2009000264A1 (de)
CO (1) CO6300843A2 (de)
CR (1) CR11613A (de)
CY (1) CY1112113T1 (de)
DK (1) DK2252286T3 (de)
EA (1) EA022711B1 (de)
EC (1) ECSP10010381A (de)
ES (1) ES2372148T3 (de)
FR (1) FR2926993B1 (de)
HR (1) HRP20110858T8 (de)
IL (1) IL207442A0 (de)
JO (1) JO2820B1 (de)
MA (1) MA32128B1 (de)
MX (1) MX2010008653A (de)
MY (1) MY150776A (de)
NI (1) NI201000135A (de)
NZ (1) NZ587232A (de)
PA (1) PA8815101A1 (de)
PE (1) PE20091410A1 (de)
PL (1) PL2252286T3 (de)
PT (1) PT2252286E (de)
RS (1) RS52046B (de)
SI (1) SI2252286T1 (de)
TW (1) TWI402071B (de)
UA (1) UA99510C2 (de)
UY (1) UY31640A1 (de)
WO (1) WO2009115666A2 (de)
ZA (1) ZA201005611B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2951945B1 (fr) * 2009-11-05 2013-08-09 Sanofi Aventis Composition pharmaceutique
AU2014346668C1 (en) 2013-11-08 2018-04-26 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
US10714230B2 (en) * 2017-12-06 2020-07-14 C3Nano Inc. Thin and uniform silver nanowires, method of synthesis and transparent conductive films formed from the nanowires
CN110604733A (zh) * 2019-09-19 2019-12-24 同济大学 青蒿素类药物与其它药物联用在制备抗疟疾药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1058717A (zh) * 1990-08-08 1992-02-19 中国人民解放军军事医学科学院微生物流行病研究所 抗疟新药—复方蒿甲醚及其制备方法
FR2796642B1 (fr) * 1999-07-21 2001-10-19 Centre Nat Rech Scient Precurseurs de sels de bis-ammonium quaternaire et leurs applications comme prodrogues ayant une activite anti-parasitaire
JP2003050535A (ja) * 2001-08-07 2003-02-21 T-Zone Corp ネットワーク教育システム、ネットワーク教育方法、および、プログラム
FR2884715B1 (fr) * 2005-04-20 2007-06-15 Sanofi Aventis Sa Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme

Also Published As

Publication number Publication date
PT2252286E (pt) 2011-12-07
EP2252286A2 (de) 2010-11-24
NZ587232A (en) 2012-06-29
JP5469095B2 (ja) 2014-04-09
AU2009227092A1 (en) 2009-09-24
TW201000098A (en) 2010-01-01
CL2009000264A1 (es) 2010-04-09
CN101980706B (zh) 2013-11-27
RS52046B (en) 2012-04-30
PA8815101A1 (es) 2009-09-17
CY1112113T1 (el) 2015-11-04
AP2613A (en) 2013-03-13
NI201000135A (es) 2011-04-27
EA022711B1 (ru) 2016-02-29
IL207442A0 (en) 2010-12-30
AU2009227092B2 (en) 2014-08-07
AR070581A1 (es) 2010-04-21
BRPI0907484A2 (pt) 2019-09-24
CA2714184A1 (fr) 2009-09-24
DK2252286T3 (da) 2011-12-19
US8304440B2 (en) 2012-11-06
HRP20110858T8 (hr) 2012-02-29
TWI402071B (zh) 2013-07-21
FR2926993A1 (fr) 2009-08-07
CR11613A (es) 2010-11-22
SI2252286T1 (sl) 2012-01-31
HK1152892A1 (en) 2012-03-16
JO2820B1 (en) 2014-09-15
KR20100137442A (ko) 2010-12-30
ZA201005611B (en) 2012-06-27
UY31640A1 (es) 2009-08-31
EA201070923A1 (ru) 2011-02-28
MY150776A (en) 2014-02-28
ECSP10010381A (es) 2010-11-30
CN101980706A (zh) 2011-02-23
UA99510C2 (ru) 2012-08-27
US20110160254A1 (en) 2011-06-30
PE20091410A1 (es) 2009-10-14
FR2926993B1 (fr) 2011-03-11
AP2010005353A0 (en) 2010-08-31
MA32128B1 (fr) 2011-03-01
WO2009115666A2 (fr) 2009-09-24
MX2010008653A (es) 2011-03-04
ES2372148T3 (es) 2012-01-16
HRP20110858T1 (hr) 2012-01-31
JP2011514319A (ja) 2011-05-06
WO2009115666A3 (fr) 2009-12-23
PL2252286T3 (pl) 2012-02-29
EP2252286B1 (de) 2011-08-24
CO6300843A2 (es) 2011-07-21

Similar Documents

Publication Publication Date Title
EP2376421A4 (de) Nebenprodukt-derivate aus einem cyclohexanoxidationsverfahren und verwendungsverfahren dafür
EP2410005A4 (de) Formkörper, verfahren zur herstellung des formkörpers, elektronisches geräteelement und elektronisches gerät
EP2321034A4 (de) Verfahren zur co2-abscheidung und anlage
EP2094085A4 (de) Anti-cholesterin-verbindungen und anwendungsverfahren dafür
EP2262009A4 (de) Lichtemittierende vorrichtung und herstellungsverfahren dafür
EP2050319A4 (de) Verfahren zur herstellung von leitern und halbleitern
EP2269788A4 (de) Rekombiniertes bambusschnittmaterial und herstellungsverfahren dafür
ATE531720T1 (de) Aza-benzofuranylverbindungen und anwendungsverfahren dafür
EP2394958A4 (de) Ddr-zeolithpulver und verfahren zur herstellung des ddr-zeolithpulvers
EP3821910C0 (de) Oligosaccharid und verfahren zur herstellung davon
BRPI0814994A2 (pt) Métodos químicos para tratamento de uma matéria-prima de metátese
DE10832374T8 (de) Gemustertes implantat und verfahren dafür
BRPI0906305A2 (pt) artigo absorvente e método de produção do mesmo
ATE550389T1 (de) Verbunde aus anorganischen und/oder organischen mikropartikeln und nanodolomitpartikeln
EP2175504A4 (de) Organisches elektrolumineszenzelement und verfahren zu seiner herstellung
ATE514637T1 (de) Sprühvorrichtung und herstellungsverfahren dafür
EP2138634A4 (de) Nassvliesstoff und filter
HUE049880T2 (hu) Anyag és eljárások Her-3-mal összefüggõ betegségek kezelésére vagy megelõzésére
ATE511509T1 (de) Azaindolylverbindungen und anwendungsverfahren
EP2383242A4 (de) Mnzn-ferritkern und verfahren zu seiner herstellung
EP2442373A4 (de) Lichtemittierende vorrichtung und herstellungsverfahren dafür
EP2383241A4 (de) Mnznco-ferritkern und verfahren zu seiner herstellung
EP2254530A4 (de) Nachgiebige stents und herstellungsverfahren
BRPI0820548A2 (pt) Métodos para a formação de artigos microsporosos e microbicidas
PL2512273T3 (pl) Element składowy wyrobu do palenia

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2252286

Country of ref document: EP